Easton Pharmaceuticals, Inc. (EAPH)

[lowe6er]

Topical Alprostadil for Female Sexual Arousal Disorder


Information source: VIVUS, Inc.
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

http://www.druglib.com/trial/48/NCT00324948.html

Condition(s) targeted: Sexual Dysfunction, Physiological

Intervention: Topical alprostadil (PGE-1) (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: VIVUS, Inc.

Official(s) and/or principal investigator(s):
Sam Teichman, MD, Study Director, Affiliation: Vivus Clinical Research Department